Respiratory function in amyotrophic lateral sclerosis patients. The role of sleep studies.
OBJECTIVE
Respiratory function decline in association with sleep breathing abnormalities in Amyotrophic Lateral Sclerosis (ALS) patients are fully recognized as crucial manifestations in the natural course of the disease, severely affecting the prognosis. The aim of this study was to evaluate the respiratory function at daytime and during sleep in a population of ALS patients and investigate the necessity of sleep study performance for the appropriate management of the disease.


METHODS
Twenty eight (10 male, 18 female) unselected patients with ALS, were evaluated in terms with their functional status by means of the ALS Functional Scale (ALSFSC). Baseline anthropometric measurements, pulmonary function tests and arterial blood gases analysis were performed, as well as evaluation of patients' perception of dyspnoea. A polysomnography was performed using a multichannel ambulatory recording.


RESULTS
Nineteen patients had sleep disordered breathing with an RDI (Respiratory Disorder Index)>5/h (from 5.6/h to 83/h) and 10 patients had an RDI>15/h. All patients had impaired functional capacity by the ALSFSC and 11 patients (39.3%) reported mild to moderate dyspnoea. FVC was below 80% predictive value in 22 patients and in 8 patients hypoxaemia (PaO2<80 mmHg) and in 12 patients hypercapnia (PaCO2>40 mmHg) was present. There was no correlation found between spirometric values, maximum inspiratory and expiratory pressures and sleep study parameters. There was a significant correlation between PaCO2 and RDI (r=0.498, p<0.01), and PaO2 with nocturnal hypoxaemia (average SpO2, r=0.436,p<0.05).


CONCLUSIONS
Sleep-breathing abnormality is common in ALS patients even in the absence of documented respiratory failure. Clinical evaluation and respiratory function tests alone may not be sufficient to predict sleep disordered breathing (SDB) and nocturnal breathing assessment should be included in the evaluation of respiratory function.
Tsara
V
V
2nd Chest Department, G. Papanikolaou Hospital, Thessaloniki, Greece. bpneumonologiki@yahoo.gr
Serasli
E
E
Steiropoulos
P
P
Tsorova
A
A
Antoniadou
M
M
Zisi
P
P
Eur Respir J. 2000 Feb;15(2):332-7
10706501
Brain. 2001 Oct;124(Pt 10):2000-13
11571218
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):849-56
10712332
Eur Respir J. 2003 Feb;21(2):253-9
12608438
J Neurol Sci. 1997 Oct;152 Suppl 1:S29-35
9419051
Neurology. 2001 Dec 11;57(11):2040-4
11739823
Sleep. 1999 Aug 1;22(5):667-89
10450601
Eur Respir J. 1997 Jul;10(7):1614-21
9230256
Chest. 1996 Sep;110(3):664-9
8797409
Amyotroph Lateral Scler. 2007 Apr;8(2):101-5
17453638
Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):160-5
14635507
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):31-5
12745616
Am J Respir Crit Care Med. 1998 Sep;158(3):734-41
9730998
Chest. 1993 Feb;103(2):508-13
8432145
J Neurol Sci. 1999 Mar 15;164(1):37-43
10385045
Arch Neurol. 1996 Feb;53(2):141-7
8639063